Cargando…

DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism

Ischemia-reperfusion (I/R) could cause heart irreversible damage, which is tightly combined with glucose metabolism disorder. It is demonstrated that GLUT4 (glucose transporter 4) translocation is critical for glucose metabolism in the cardiomyocytes under I/R injury. Moreover, DRD4 (dopamine recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xue-song, Zeng, Jing, Yang, Yu-xue, Qi, Chun-lei, Xiong, Ting, Wu, Geng-ze, Zeng, Chun-yu, Wang, Da-xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873565/
https://www.ncbi.nlm.nih.gov/pubmed/33584304
http://dx.doi.org/10.3389/fphar.2020.619426
_version_ 1783649410488467456
author Liu, Xue-song
Zeng, Jing
Yang, Yu-xue
Qi, Chun-lei
Xiong, Ting
Wu, Geng-ze
Zeng, Chun-yu
Wang, Da-xin
author_facet Liu, Xue-song
Zeng, Jing
Yang, Yu-xue
Qi, Chun-lei
Xiong, Ting
Wu, Geng-ze
Zeng, Chun-yu
Wang, Da-xin
author_sort Liu, Xue-song
collection PubMed
description Ischemia-reperfusion (I/R) could cause heart irreversible damage, which is tightly combined with glucose metabolism disorder. It is demonstrated that GLUT4 (glucose transporter 4) translocation is critical for glucose metabolism in the cardiomyocytes under I/R injury. Moreover, DRD4 (dopamine receptor D4) modulate glucose metabolism, and protect neurocytes from anoxia/reoxygenation (A/R) injury. Thus, DRD4 might regulate myocardial I/R injury in association with GLUT4-mediated glucose metabolism. However, the effects and mechanisms are largely unknown. In the present study, the effect of DRD4 in heart I/R injury were studied ex vivo and in vitro. For I/R injury ex vivo, DRD4 agonist (PD168077) was perfused by Langendorff system in the isolated rat heart. DRD4 activated by PD168077 improved cardiac function in the I/R-injured heart as determined by the left ventricular developed pressure (LVDP), +dp/dt, and left ventricular end diastolic pressure (LVEDP), and reduced heart damage evidenced by infarct size, the release of troponin T (TNT) and lactate dehydrogenase (LDH). DRD4 activation diminished I/R injury induced apoptosis and enhanced cell viability impaired by I/R injury in cardiomyocyte, showed by TUNEL staining, flow cytometer and CCK8 assay. Furthermore, DRD4 activation did not change total GULT4 protein expression level but increased the membrane GULT4 localization determined by western blot. In terms of mechanism, DRD4 activation increased pPI3K/p-AKT but not the total PI3K/AKT during anoxia/reoxygenation (A/R) injury in vitro. Interestingly, PI3K inhibitor, Wortmannin, blocked PI3K/AKT pathway and depleted the membrane GULT4, and further promoted apoptosis showed by TUNEL staining, flow cytometer, western blot of cleaved caspase 3, BAX and BCL2 expression. Thus, DRD4 activation exerted a protective effect against I/R injury by promoting GLUT4 translocation depended on PI3K/AKT pathway, which enhanced the ability of glucose uptake, and ultimately reduced the apoptosis in cardiomyocytes.
format Online
Article
Text
id pubmed-7873565
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78735652021-02-11 DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism Liu, Xue-song Zeng, Jing Yang, Yu-xue Qi, Chun-lei Xiong, Ting Wu, Geng-ze Zeng, Chun-yu Wang, Da-xin Front Pharmacol Pharmacology Ischemia-reperfusion (I/R) could cause heart irreversible damage, which is tightly combined with glucose metabolism disorder. It is demonstrated that GLUT4 (glucose transporter 4) translocation is critical for glucose metabolism in the cardiomyocytes under I/R injury. Moreover, DRD4 (dopamine receptor D4) modulate glucose metabolism, and protect neurocytes from anoxia/reoxygenation (A/R) injury. Thus, DRD4 might regulate myocardial I/R injury in association with GLUT4-mediated glucose metabolism. However, the effects and mechanisms are largely unknown. In the present study, the effect of DRD4 in heart I/R injury were studied ex vivo and in vitro. For I/R injury ex vivo, DRD4 agonist (PD168077) was perfused by Langendorff system in the isolated rat heart. DRD4 activated by PD168077 improved cardiac function in the I/R-injured heart as determined by the left ventricular developed pressure (LVDP), +dp/dt, and left ventricular end diastolic pressure (LVEDP), and reduced heart damage evidenced by infarct size, the release of troponin T (TNT) and lactate dehydrogenase (LDH). DRD4 activation diminished I/R injury induced apoptosis and enhanced cell viability impaired by I/R injury in cardiomyocyte, showed by TUNEL staining, flow cytometer and CCK8 assay. Furthermore, DRD4 activation did not change total GULT4 protein expression level but increased the membrane GULT4 localization determined by western blot. In terms of mechanism, DRD4 activation increased pPI3K/p-AKT but not the total PI3K/AKT during anoxia/reoxygenation (A/R) injury in vitro. Interestingly, PI3K inhibitor, Wortmannin, blocked PI3K/AKT pathway and depleted the membrane GULT4, and further promoted apoptosis showed by TUNEL staining, flow cytometer, western blot of cleaved caspase 3, BAX and BCL2 expression. Thus, DRD4 activation exerted a protective effect against I/R injury by promoting GLUT4 translocation depended on PI3K/AKT pathway, which enhanced the ability of glucose uptake, and ultimately reduced the apoptosis in cardiomyocytes. Frontiers Media S.A. 2021-01-27 /pmc/articles/PMC7873565/ /pubmed/33584304 http://dx.doi.org/10.3389/fphar.2020.619426 Text en Copyright © 2021 Liu, Zeng, Yang, Qi, Xiong, Wu, Zeng and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (http://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Xue-song
Zeng, Jing
Yang, Yu-xue
Qi, Chun-lei
Xiong, Ting
Wu, Geng-ze
Zeng, Chun-yu
Wang, Da-xin
DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism
title DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism
title_full DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism
title_fullStr DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism
title_full_unstemmed DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism
title_short DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism
title_sort drd4 mitigates myocardial ischemia/reperfusion injury in association with pi3k/akt mediated glucose metabolism
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873565/
https://www.ncbi.nlm.nih.gov/pubmed/33584304
http://dx.doi.org/10.3389/fphar.2020.619426
work_keys_str_mv AT liuxuesong drd4mitigatesmyocardialischemiareperfusioninjuryinassociationwithpi3kaktmediatedglucosemetabolism
AT zengjing drd4mitigatesmyocardialischemiareperfusioninjuryinassociationwithpi3kaktmediatedglucosemetabolism
AT yangyuxue drd4mitigatesmyocardialischemiareperfusioninjuryinassociationwithpi3kaktmediatedglucosemetabolism
AT qichunlei drd4mitigatesmyocardialischemiareperfusioninjuryinassociationwithpi3kaktmediatedglucosemetabolism
AT xiongting drd4mitigatesmyocardialischemiareperfusioninjuryinassociationwithpi3kaktmediatedglucosemetabolism
AT wugengze drd4mitigatesmyocardialischemiareperfusioninjuryinassociationwithpi3kaktmediatedglucosemetabolism
AT zengchunyu drd4mitigatesmyocardialischemiareperfusioninjuryinassociationwithpi3kaktmediatedglucosemetabolism
AT wangdaxin drd4mitigatesmyocardialischemiareperfusioninjuryinassociationwithpi3kaktmediatedglucosemetabolism